Lipella Pharmaceuticals Inc. LIPO
0.00 USD 0.00 (-16.67%)
At closeNov 4, 2026, 4:00 PM EST
1.80 +1.80 +359,920.00%
After hours · Nov 4, 4:00 PM ET
0.0327 Day range 0.058
0.0002 52-week range 0.545
- YTD
- -99.72%
- 1 year
- -99.89%
Ownership
Held by insiders 29.37%
Held by institutions 0.88%
Float held by institutions 1.24%
Institutions 5
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Group Inc | 0.36% | 4,315 | 13.38K | Sep 29, 2024 |
| Geode Capital Management, LLC | 0.26% | 3,114 | 9.65K | Sep 29, 2024 |
| HRT Financial LP | 0.18% | 2,202 | 6.83K | Sep 29, 2024 |
| Tower Research Capital LLC (TRC) | 0.08% | 962 | 2.98K | Sep 29, 2024 |
| Bank of America Corporation | 0.00% | 6 | 18 | Sep 29, 2024 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Extended Market Index Fund | 0.36% | 4,315 | 13.38K | Sep 29, 2024 |
| Fidelity Extended Market Index Fund | 0.25% | 3,057 | 9.48K | Oct 30, 2024 |
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| CHANCELLOR MICHAEL B. | Officer, Director and Beneficial Owner | Stock Award(Grant) | Mar 12, 2024 | 877,637 |
| KAUFMAN JONATHAN | Chief Executive Officer | Purchase | May 13, 2024 | 898,849 |